Who
Deborah Birx
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Armata Pharmaceuticals; Director, Innoviva.
In numbers
- Trades disclosed
- 21
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 22 Mar 2021
- Last trade
- 10 Jul 2026
- Last filed
- 14 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jul 2026filed 14 Jul 2026 | ARMP Armata PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $60K14,041 at $4.26 | filing |
| 10 Jul 2026filed 14 Jul 2026 | ARMP Armata PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $60K14,041 at $4.26 | filing |
| 14 Mar 2026filed 17 Mar 2026 | ARMP Armata PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $52K4,919 at $10.54 | filing |
| 14 Mar 2026filed 17 Mar 2026 | ARMP Armata PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $52K4,919 at $10.54 | filing |
| 9 Mar 2026filed 11 Mar 2026 | ARMP Armata Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —421,226 at $0.00 | filing |
| 9 Mar 2026filed 11 Mar 2026 | ARMP Armata Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —421,226 at $0.00 | filing |
| 10 Jul 2025filed 14 Jul 2025 | ARMP Armata PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $31K13,637 at $2.27 | filing |
| 14 Mar 2025filed 25 Apr 2025 | ARMP Armata PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $12K6,061 at $1.95 | filing |
| 5 Feb 2025filed 7 Feb 2025 | ARMP Armata Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —240,000 at $0.00 | filing |
| 10 Jul 2024filed 25 Apr 2025 | ARMP Armata PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $61K22,925 at $2.68 | filing |
| 14 Mar 2024filed 18 Mar 2024 | ARMP Armata Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —240,000 at $0.00 | filing |
| 14 Mar 2024filed 18 Mar 2024 | ARMP Armata PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 21 Dec 2023filed 26 Dec 2023 | ARMP Armata Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 21 Dec 2023filed 26 Dec 2023 | ARMP Armata PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 22 May 2023filed 24 May 2023 | INVA Innovivaoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 22 May 2023filed 24 May 2023 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code A | —16,495 at $0.00 | filing |
| 25 Apr 2022filed 27 Apr 2022 | INVA Innovivaoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 25 Apr 2022filed 27 Apr 2022 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code A | —12,647 at $0.00 | filing |
| 14 May 2021filed 20 May 2021 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code A | —17,482 at $0.00 | filing |
| 29 Mar 2021filed 30 Mar 2021 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code A | —1,612 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.